速递｜发现GLP-1的生物化学家，荣获2026年金伯利奖

Core Insights - The article highlights the recognition of Dr. Svetlana Mojsov for her groundbreaking work on GLP-1, which plays a crucial role in insulin secretion and glucose metabolism, leading to advancements in diabetes and obesity treatments [4][10]. Group 1: Award and Recognition - Dr. Svetlana Mojsov received the prestigious Kimberly Prize in Biochemistry and Molecular Genetics, with a monetary award of $250,000, for her discovery of GLP-1 [4][7]. - The Kimberly Prize, established in 2023, is the highest monetary award for biochemistry in American universities, aimed at honoring significant contributions to biochemical research with direct clinical applications [11]. Group 2: Contributions to Science - Mojsov's research has established GLP-1 as a potent incretin hormone, which stimulates insulin secretion and lowers blood glucose levels, paving the way for the development of GLP-1 receptor agonists like liraglutide and semaglutide [10]. - Her work has been recognized with numerous awards, including the Lasker-DeBakey Clinical Medical Research Award and the Breakthrough Prize, underscoring her impact on peptide science and glucose metabolism [10]. Group 3: Future Engagements - Dr. Mojsov will deliver a public lecture at Northwestern University's Feinberg School of Medicine and participate in the award ceremony in Spring 2026 [5].